Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups
about
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selectionEnd-sequence profiling: sequence-based analysis of aberrant genomesThe Role of Genomic Profiling in Advanced Breast Cancer: The Two Faces of JanusGenomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumorsFunctional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersFGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerInhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical applicationBET domain co-regulators in obesity, inflammation and cancerAn integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomasDetection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction.AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines.Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.The unique expression and function of miR-424 in human placental trophoblasts.Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes.Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I studyGenomic instability in breast cancer: pathogenesis and clinical implicationsGenetic alterations of chromosome 8 genes in oral cancer.Copy number analysis identifies novel interactions between genomic loci in ovarian cancerCortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.Fibroblast growth factor receptor 1 activation in mammary tumor cells promotes macrophage recruitment in a CX3CL1-dependent mannerDifferential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growthAn array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosisATHENA: Identifying interactions between different levels of genomic data associated with cancer clinical outcomes using grammatical evolution neural network.Rationale for targeting fibroblast growth factor receptor signaling in breast cancerChromosome 2 (2p16) abnormalities in Carney complex tumours.Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation.FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal CarcinomaAmplification patterns of three genomic regions predict distant recurrence in breast carcinoma.Partial PTEN deletion is linked to poor prognosis in breast cancerFGFR2 gene amplification and clinicopathological features in gastric cancerTargeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo.Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer.Functional characterization of the 19q12 amplicon in grade III breast cancersFGFR1 amplification in squamous cell carcinoma of the lung.FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma.C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance
P2860
Q24605762-31D07094-5A74-4142-AF8D-799E997578CDQ24670275-444ED06F-894B-4893-832B-4D498CDCA13AQ26740184-A80E0806-3E45-4305-A4B4-816B2E445C67Q26998790-C2713D2A-37D2-48CB-B54E-94CF8547947FQ26998955-047A6413-1B42-4362-8F64-F8708676DB5CQ27851554-FB5A59E7-7746-46A5-85A4-00AFD91DDB7DQ28079309-533C925C-5A5D-4664-A805-23CC2CB17594Q28269301-614FCBE3-2F34-485E-9636-953F6FB7A35DQ28487526-9D03B265-F65F-401D-8E8F-79695066DE26Q30879242-B3B5292D-4EAE-440A-8B91-36EBF4EF5A09Q33241980-5E9A617A-ADC4-4305-AF81-0E09CD6A6810Q33260375-96E066B7-B185-49D7-A2E8-44AC5A8A8109Q33826132-2529B42C-96B8-4F4B-AF76-EE0B179D5EE0Q33874621-5F5AF4AF-3A52-4234-9FB6-80D2C7F66D5BQ33885479-94494018-60AD-48A9-B791-636EE21435A1Q33998514-CB6B867D-8394-4B73-AB3F-573CAE8251FDQ34048738-3F51E8DE-83AD-4E68-9F32-BF411B6EE7ACQ34117394-4034C7DE-B226-4207-B6D2-27B1A17C3DB7Q34190232-FBE61807-263A-46B3-9D40-C3C4A606C71AQ34430280-92F36790-46A1-4FA3-AFB6-10A907C5B5F7Q34490810-C857C13F-7BE6-4EDA-9702-46528D50414CQ34491930-91A2E3E9-0C85-4DC5-9C9D-60300B365FC1Q35073828-003A714D-8595-4141-AB74-2616A1DB4227Q35131258-EAC7F6EF-B1BA-4189-81B6-02BCECA7E6EBQ35442035-15D2F89C-6E59-46A1-9FCB-75B0D14F7C1FQ35793260-9E95FC4A-6688-4889-AAAC-81509147F959Q35794378-2A04246C-FA43-4F06-B53D-EB05CBD40D81Q35837391-53604AD4-1164-4427-82FA-4664C69CB041Q35855473-123C262B-FD5F-470B-B48C-546EF64AE53CQ35870069-28985CF9-0713-4277-BCC2-6FE7F3159E21Q35879874-E213046B-F755-4D9A-9B0D-23DEF7681FC2Q35881055-B2A93AB3-C647-4849-8878-BAB0556559FBQ35990106-79FC14E3-50B8-42B7-B010-4A2D48BC4C8EQ36097122-2450507E-AE88-4994-9F22-96CB02C376B9Q36204224-5E48701B-991A-4036-A7E5-F9F8340923A3Q36245320-38D11690-CD16-4631-B36A-A4149C87B62CQ36245567-94F90E3F-9210-41A2-BCC1-1CEFE46CA363Q36406190-A6D64DA2-99DF-423E-BBD8-63FDE0772933Q36524946-A458895B-22D0-4972-A056-03C6B0DCF4DCQ36621638-9985869A-43A4-4A59-BBDC-8D3CF6E49CED
P2860
Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups
description
im Oktober 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 October 1997
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 1997
@uk
name
Mapping of DNA amplifications ...... efinition of phenotypic groups
@en
Mapping of DNA amplifications ...... efinition of phenotypic groups
@nl
type
label
Mapping of DNA amplifications ...... efinition of phenotypic groups
@en
Mapping of DNA amplifications ...... efinition of phenotypic groups
@nl
prefLabel
Mapping of DNA amplifications ...... efinition of phenotypic groups
@en
Mapping of DNA amplifications ...... efinition of phenotypic groups
@nl
P2093
P1433
P1476
Mapping of DNA amplifications ...... efinition of phenotypic groups
@en
P2093
Rodriguez C
Simony-Lafontaine J
P304
P407
P577
1997-10-01T00:00:00Z